Dana Mead

Who is Dana Mead?

Dana Mead joined Kleiner Perkins Caufield Byers as a partner in May 2005 to work in the life sciences practice.For

the past 23 years, Dana's career has focused on identifying new medical

technologies, developing new markets and therapies, and building

world-class management teams. He has worked with physician thought

leaders around the world representing 10 different medical specialties.

At KPCB, Dana leverages experience gained from his venture-funded,

start-up management roles and board participation to support

entrepreneurs and innovators dedicated to making a real difference in

the lives of millions suffering from life-limiting disease.Prior

to joining KPCB, Dana was President of Guidant Vascular Intervention, a

fully integrated billion dollar division with over 4500 employees.

Since joining Guidant in 1992, he held positions of increasing

responsibility including Vice President and General Manager, Cardiac

Vascular Surgery; Vice President and General Manager, Stents,

Vascular Intervention Group; President, Japan and A/P Operations based

in Tokyo; and Vice President, Corporate Relations and Policy with

responsibility for investor relations, corporate communications,

corporate marketing and public policy initiatives. Prior to joining

Guidant, Dana worked in various sales and marketing roles at Allergan,

Inc. and Johnson Johnson. A native of Connecticut, Dana received

his Bachelor's degree from Lafayette College and holds an MBA degree

from the University of Southern California. Dana serves on the boards

of the California Healthcare Institute (CHI), the Cardiovascular

Research Foundation (CRF), AesThera, Inc., Corventis, Inc., Sinexus,

Spotlight Surgical, Navigenics, Synvascular, OtisMed Corporation and

Lucille Packard Children's Hospital (LPCH).